GIP (Active) ELISA - Cosmo Bio Co.,Ltd.

Antibodies

>

GIP (Active) ELISA

glucose-dependent insulinotropic polypeptide

Catalog No.: YII-YK250-EX
Size: 1KIT
Price: ¥79000
$1054
antigen/source: GIP (Active)
Storage: 4C
@
Immunogen: Human
Reacts with: Human
Measurement Range: 3.9- 250 pg / mL
Purpose: Measurement of Human GIP (Active) in plasma samples
component: Antibody: X
Plate: X
Coating: X
Control: -
Standard: X
Labeling: X
Substrate: X
Others: X
1. Antibody coated plate
2. Standard
3. HRP labeled antibody solution
4. Enzyme substrate solution
5. Stopping solution
6. Buffer solution
7. Washing solution (concentrated)
8. Adhesive foil

Other:

 Supplementary 
Sandwich
 Applicable sample 
Human plasma (EDTA-2Na + DPP-4
inhibitor) and culture medium supernatant
[Other]
 Background 
The incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagons-like peptide-1 (GLP-1), are a group of gastrointestinal hormones that cause an increase in the amount of insulin released from the beta cells of the islets of Langerhans after ingestion of food.
This ELISA kit has high specificity to human GIP (1-42) active form and shows no crossreactivity to human GIP (3-42) inactive form.
 Assay range 
3.9~250 pg/mL


Reference:

•  Brown JC. et al., J.Physiol. 209 57-64 (1970)
•  Jornvall H. et al., FEBS Lett. 123 205-210 (1981)
•  Moody AJ. et al., Diabetologia 21 306 abstr. (1981)
•  Carlquist M. et al., Eur.J. Biochem. 145 573-577 (1984)
•  Moody AJ. et al., FEBS Lett. 172 142-148 (1984)
•  Takeda J. et al., Proc Natl Acad Sci USA 84 7005-7008 (1987)
•  Pederson RA, Biochemistry and Physiology, eds, Walsh, J.H.& Dockray, G.J. (Raven, New York), pp217-260 (1994)
•  Rabinovitch A. and Dupre J., Endocrinology 94 1139-1144 (1974)
•  Dupre J. et al., J. Clin. Endocrinol. Metab. 37 826-828 (1973)
•  Elahi D. et al., Am. J. Physiol. 237 E185-E191 (1979)
•  Krarup T. et.al., J. Clin. Endocrinol. Metab. 56 1306-12 (1983)
•  Naitoh R. et al., Biochem Biophys Res Commun. 376 21-25 (2008)
•  Miyawaki K. et al., Proc Natl Acad Sci USA. 96 14843-14847 (1999)
•  Miyawaki K. et al.,Nat Med. 8 738-742 (2002)
•  Tsukiyama K. et al., Mol Endocrinol. 20 1644-51 (2006)
 
>